PL3717635T3 - Komórki multi -chimeryczne i terapia w transplantacji i leczeniu niedoboru odporności i zaburzeń genetycznych - Google Patents

Komórki multi -chimeryczne i terapia w transplantacji i leczeniu niedoboru odporności i zaburzeń genetycznych

Info

Publication number
PL3717635T3
PL3717635T3 PL18830033.9T PL18830033T PL3717635T3 PL 3717635 T3 PL3717635 T3 PL 3717635T3 PL 18830033 T PL18830033 T PL 18830033T PL 3717635 T3 PL3717635 T3 PL 3717635T3
Authority
PL
Poland
Prior art keywords
transplantation
therapy
treatment
genetic disorders
immune deficiencies
Prior art date
Application number
PL18830033.9T
Other languages
English (en)
Inventor
Maria Siemionow
Original Assignee
The Board Of Trustees Of The University Of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The University Of Illinois filed Critical The Board Of Trustees Of The University Of Illinois
Publication of PL3717635T3 publication Critical patent/PL3717635T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/418—Antigens related to induction of tolerance to non-self
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL18830033.9T 2017-11-28 2018-11-28 Komórki multi -chimeryczne i terapia w transplantacji i leczeniu niedoboru odporności i zaburzeń genetycznych PL3717635T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762591397P 2017-11-28 2017-11-28
PCT/US2018/062736 WO2019108584A1 (en) 2017-11-28 2018-11-28 Multi-chimeric cell and therapy for transplantation and treatment of immune deficiencies and genetic disorders

Publications (1)

Publication Number Publication Date
PL3717635T3 true PL3717635T3 (pl) 2026-02-16

Family

ID=64949384

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18830033.9T PL3717635T3 (pl) 2017-11-28 2018-11-28 Komórki multi -chimeryczne i terapia w transplantacji i leczeniu niedoboru odporności i zaburzeń genetycznych

Country Status (9)

Country Link
US (1) US12391927B2 (pl)
EP (1) EP3717635B1 (pl)
JP (1) JP2021503961A (pl)
CN (1) CN111406106A (pl)
AU (1) AU2018375315B2 (pl)
CA (1) CA3116328A1 (pl)
ES (1) ES3057887T3 (pl)
PL (1) PL3717635T3 (pl)
WO (1) WO2019108584A1 (pl)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538722A (en) 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
DE10050334A1 (de) * 2000-10-11 2002-04-25 Gsf Forschungszentrum Umwelt Verwendung von Stammzellen und CD6-depletierten Stammzellen zur Toleranzinduktion gegenüber allogenen Transplantaten und/oder zur Leukämiebehandlung
CA2486621A1 (en) * 2002-05-22 2003-12-04 The Cleveland Clinic Foundation Induction and maintenance of tolerance to composite tissue allografts
CA2484629A1 (en) * 2002-05-31 2003-12-11 Apollo Life Sciences Pty Limited Electrofusion of cells and apparatus therefore
JP2004147531A (ja) * 2002-10-29 2004-05-27 Asahi Kasei Corp 細胞処理方法
CA2475174A1 (en) 2004-07-19 2006-01-19 Institut Pasteur Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells
US20070253931A1 (en) * 2006-01-12 2007-11-01 Osiris Therapeutics, Inc. Use of mesenchymal stem cells for treating genetic diseases and disorders
US20080286249A1 (en) * 2006-01-12 2008-11-20 Varney Timothy R Use of mesenchymal stem cells for treating genetic diseases and disorders
AU2009245760B2 (en) * 2008-05-07 2014-11-20 Bone Therapeutics S.A. Human bone-forming cells in the treatment of conditions and bone diseases associated with immunodeficiency or immunosuppression
CA2703428A1 (en) * 2010-05-11 2011-11-11 Mcgill University Health Center Pooled cord blood units
WO2014087658A1 (en) * 2012-12-07 2014-06-12 Kuraray Co., Ltd. Method of cell fusion and fusion cells
US20150050300A1 (en) * 2013-08-16 2015-02-19 Peter K. Law Disease prevention and alleviation by human myoblast transplantation
US10071121B2 (en) 2014-11-14 2018-09-11 San Diego State University (Sdsu) Foundation Cardiac, mesenchymal and endothelial progenitor cell (CPC) chimeras and methods for making and using them
CA2988137C (en) * 2015-06-11 2021-01-26 Maria Siemionow Muscular dystrophy chimeric cells and method for treating muscular dystrophies

Also Published As

Publication number Publication date
CN111406106A (zh) 2020-07-10
CA3116328A1 (en) 2019-12-06
WO2019108584A1 (en) 2019-06-06
AU2018375315B2 (en) 2025-05-01
ES3057887T3 (en) 2026-03-05
EP3717635B1 (en) 2025-10-22
AU2018375315A1 (en) 2020-06-04
JP2021503961A (ja) 2021-02-15
US12391927B2 (en) 2025-08-19
EP3717635A1 (en) 2020-10-07
US20200263141A1 (en) 2020-08-20

Similar Documents

Publication Publication Date Title
IL270982A (en) Articles of manufacture and methods for treatment using adoptive cell therapy
SG11202105502RA (en) Methods for treatment using adoptive cell therapy
GB2595063B (en) Modified cells and methods of therapy
SG11201803043VA (en) Derivation of human skin organoids from pluripotent stem cells
PL3242947T3 (pl) Terapia genowa i elektroporacja do leczenia zmian złośliwych
ZA201602839B (en) Methods of using interleukin-10 for treating diseases and disorders
IL283713B (en) Use of cellular chemotherapy for the treatment of eye disorders and devices for use
EP3259017A4 (en) Nerve stimulation for treatment of diseases and disorders
IL274865A (en) Treatment methods with asparaginase
ZA201702214B (en) Methods of using interleukin-10 for treating diseases and disorders
IL269302A (en) Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating ire1-related diseases and disorders
EP2986306A4 (en) METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
EP3160493A4 (en) Compositions and methods to regulate renalase in the treatment of diseases and disorders
EP3518943A4 (en) METHOD FOR ADAPTIVE CELL THERAPY
EP3038642A4 (en) Methods of using interleukin-10 for treating diseases and disorders
PL3389620T3 (pl) Kompozycje stymulujące komórki macierzyste i sposoby leczenia melasmy
EP3213761A4 (en) Novel treatment of retina and nerve using laminin
EP3097108B8 (en) Use of psoralen derivatives and combination therapy for treatment of cell proliferation disorders
SG10202101160RA (en) Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
GB201614415D0 (en) Enzymes for the treatment of human enterometabolic dysfunction
IL267231A (en) Methods of treating diseases associated with ilc2 cells
EP3151824A4 (en) Methods of treating neurodevelopmental diseases and disorders
PL3717635T3 (pl) Komórki multi -chimeryczne i terapia w transplantacji i leczeniu niedoboru odporności i zaburzeń genetycznych
IL262951A (en) Methods of drug therapy associated with ilc3 cells
IL262152A (en) Modulation of the immune system for the prevention and treatment of diseases and disorders